Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Depression: HELP
Christopher S. Coffey
Based on 3 articles published since 2008
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 3 published articles on Depression from 2008 through 2019, it is not possible for Expertscape to reliably rate Christopher S. Coffey's expertise on this topic.

Uncounted papers?
Aliases Coffey, Christopher   ·   Coffey, Christopher S
Work Locations
Details
Most likely:    University of Iowa   Contact    
2018
  • From the Mellen Center for Multiple Sclerosis, Neurological Institute (R.J.F., S. Natarajan, R.A.B., D.O.), the Imaging Institute (X.H., M.J.L., K.E.S., X.Z.), and the Department of Biomedical Engineering (P.J., K.N., B. Thoomukuntla), Cleveland Clinic, Cleveland, Ohio State University, Columbus (M.R.), and University of Cincinnati, Cincinnati (A.Z.) - all in Ohio · the Data Coordinating Center, Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), University of Iowa, Iowa City (C.S.C., J.B., D.E., E.K., M.K., J.D.L., J.Y.) · the National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.C.) · the Clinical Coordinating Center, NeuroNEXT, Massachusetts General Hospital, Neurological Clinical Research Institute, Harvard Partners (M.E.C., M.M., A.A., B. Thornell), the Department of Neurology, Massachusetts General Hospital, Harvard Medical School (E.C.K.), and Brigham and Women's Hospital (C.S.), Boston · patient advocate (T.G.) and Swedish Medical Center at Seattle (P.R.), Seattle · University of Rochester Medical Center, Rochester (A.G.), Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Medical Center (S.K.), Weill Cornell Medical College (J.S.P.), Columbia University Medical Center (C.S.R.), and Montefiore Medical Center, Albert Einstein College of Medicine (S.S.), New York, State University of New York (SUNY) at Stony Brook, Stony Brook (P.K.C.), SUNY Upstate Medical University, Syracuse (B.J.), and SUNY at Buffalo, Buffalo (B.W.-G.) - all in New York · MediciNova, La Jolla (K.M.), University of California at Davis, Sacramento (M.A.), and University of California at Los Angeles, Los Angeles (B.S.G.) - all in California · Washington University School of Medicine, St. Louis (R.T.N.) · Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ (J.P.D.) · NeuroRx Research, Montreal (S. Narayanan) · the School of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN (X.Z.) · University of Colorado Denver, Aurora (E.A.) · University of Alabama at Birmingham, Birmingham (K.B.) · Feinberg School of Medicine, Northwestern University, Chicago (B.A.C.) · University of Miami Miller School of Medicine, Miami (S.D.) · University of Utah, Salt Lake City (L.D.D.) · University of Texas Southwestern Medical Center, Dallas (A.F.) · University of Virginia at Charlottesville, Charlottesville (M.D.G.) · Emory University, Atlanta (N.L.) · University of Kansas Medical Center, Kansas City (S.G.L.) · Vanderbilt University, Nashville (H.M.) · University of Pittsburgh Medical Center, Pittsburgh (V.S.) · and Oregon Health and Science University, Portland (V.Y.). · Pubmed 30157388
2017
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Neurology Unit, Hospital General de Granollers, Universitat Internacional de Catalunya, Granollers, Spain. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA. · Departments of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China. · Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Laboratory of Neurodegenerative Disorders, Department of Neurology, Hospital Clínic of Barcelona, Institutd'InvestigacionsBiomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. · Institute for Neurodegenerative Disorders and Molecular NeuroImaging, New Haven, Connecticut, USA. · Department of Nuclear Medicine, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, Movement Disorders Unit. Hospital Universitario Donostia. Biodonostia Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián, Guipúzcoa, Spain. · Department of Neurology, Mount Sinai Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway. · Pubmed 28370517
2015
  • Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Institute for Neurodegenerative Disorders (IND) and Molecular NeuroImaging, LLC (MNI), New Haven, Connecticut, USA. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA. · Department of Neurobiology, Care Sciences and Society and the Alzheimer Disease Research Centre, Karolinska Institutet, Stockholm, Sweden; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. · Neurodegenerative Diseases Centre, Neuroscience Section, Department of Medicine, University of Salerno, Italy. · Institute for Ageing and Health, Newcastle University, Newcastle, England. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio, USA. · Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio, USA. · UCSD Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, California, USA. · Departments of Neurology and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. · Medivation, Inc., San Francisco, California, USA. · Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA. · Pubmed 25737166
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Christopher S. Coffey in 2008-2019 about Depression:

  • Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. 2018
  • The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies. 2017
  • Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. 2015
Show List of Full Article Records
Google Searches

Learn more about Christopher S. Coffey using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Iowa
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Iowa
2018
  • From the Mellen Center for Multiple Sclerosis, Neurological Institute (R.J.F., S. Natarajan, R.A.B., D.O.), the Imaging Institute (X.H., M.J.L., K.E.S., X.Z.), and the Department of Biomedical Engineering (P.J., K.N., B. Thoomukuntla), Cleveland Clinic, Cleveland, Ohio State University, Columbus (M.R.), and University of Cincinnati, Cincinnati (A.Z.) - all in Ohio · the Data Coordinating Center, Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), University of Iowa, Iowa City (C.S.C., J.B., D.E., E.K., M.K., J.D.L., J.Y.) · the National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.C.) · the Clinical Coordinating Center, NeuroNEXT, Massachusetts General Hospital, Neurological Clinical Research Institute, Harvard Partners (M.E.C., M.M., A.A., B. Thornell), the Department of Neurology, Massachusetts General Hospital, Harvard Medical School (E.C.K.), and Brigham and Women's Hospital (C.S.), Boston · patient advocate (T.G.) and Swedish Medical Center at Seattle (P.R.), Seattle · University of Rochester Medical Center, Rochester (A.G.), Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Medical Center (S.K.), Weill Cornell Medical College (J.S.P.), Columbia University Medical Center (C.S.R.), and Montefiore Medical Center, Albert Einstein College of Medicine (S.S.), New York, State University of New York (SUNY) at Stony Brook, Stony Brook (P.K.C.), SUNY Upstate Medical University, Syracuse (B.J.), and SUNY at Buffalo, Buffalo (B.W.-G.) - all in New York · MediciNova, La Jolla (K.M.), University of California at Davis, Sacramento (M.A.), and University of California at Los Angeles, Los Angeles (B.S.G.) - all in California · Washington University School of Medicine, St. Louis (R.T.N.) · Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ (J.P.D.) · NeuroRx Research, Montreal (S. Narayanan) · the School of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN (X.Z.) · University of Colorado Denver, Aurora (E.A.) · University of Alabama at Birmingham, Birmingham (K.B.) · Feinberg School of Medicine, Northwestern University, Chicago (B.A.C.) · University of Miami Miller School of Medicine, Miami (S.D.) · University of Utah, Salt Lake City (L.D.D.) · University of Texas Southwestern Medical Center, Dallas (A.F.) · University of Virginia at Charlottesville, Charlottesville (M.D.G.) · Emory University, Atlanta (N.L.) · University of Kansas Medical Center, Kansas City (S.G.L.) · Vanderbilt University, Nashville (H.M.) · University of Pittsburgh Medical Center, Pittsburgh (V.S.) · and Oregon Health and Science University, Portland (V.Y.). · Pubmed 30157388
2017
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Neurology Unit, Hospital General de Granollers, Universitat Internacional de Catalunya, Granollers, Spain. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA. · Departments of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China. · Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Laboratory of Neurodegenerative Disorders, Department of Neurology, Hospital Clínic of Barcelona, Institutd'InvestigacionsBiomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. · Institute for Neurodegenerative Disorders and Molecular NeuroImaging, New Haven, Connecticut, USA. · Department of Nuclear Medicine, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, Movement Disorders Unit. Hospital Universitario Donostia. Biodonostia Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián, Guipúzcoa, Spain. · Department of Neurology, Mount Sinai Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway. · Pubmed 28370517
2015
  • Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Institute for Neurodegenerative Disorders (IND) and Molecular NeuroImaging, LLC (MNI), New Haven, Connecticut, USA. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA. · Department of Neurobiology, Care Sciences and Society and the Alzheimer Disease Research Centre, Karolinska Institutet, Stockholm, Sweden; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. · Neurodegenerative Diseases Centre, Neuroscience Section, Department of Medicine, University of Salerno, Italy. · Institute for Ageing and Health, Newcastle University, Newcastle, England. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio, USA. · Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio, USA. · UCSD Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, California, USA. · Departments of Neurology and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. · Medivation, Inc., San Francisco, California, USA. · Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA. · Pubmed 25737166
Yearly article counts 011010000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.